The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity
Abstract
Vascular smooth muscle cells (VSMCs) are the major cell type in blood vessels. Unlike many other mature cell types in the adult body, VSMC do not terminally differentiate but retain a remarkable plasticity. Fully differentiated medial VSMCs of mature vessels maintain quiescence and express a range of genes and proteins important for contraction/dilation, which allows them to control systemic and local pressure through the regulation of vascular tone. In response to vascular injury or alterations in local environmental cues, differentiated/contractile VSMCs are capable of switching to a dedifferentiated phenotype characterized by increased proliferation, migration and extracellular matrix synthesis in concert with decreased expression of contractile markers. Imbalanced VSMC plasticity results in maladaptive phenotype alterations that ultimately lead to progression of a variety of VSMC-driven vascular diseases. The nature, extent and consequences of dysregulated VSMC phenotype alterations are diverse, reflecting the numerous environmental cues (e.g. biochemical factors, extracellular matrix components, physical) that prompt VSMC phenotype switching. In spite of decades of efforts to understand cues and processes that normally control VSMC differentiation and their disruption in VSMC-driven disease states, the crucial molecular mechanisms and signalling pathways that shape the VSMC phenotype programme have still not yet been precisely elucidated. In this article we introduce the physiological functions of vascular smooth muscle/VSMCs, outline VSMC-driven cardiovascular diseases and the concept of VSMC phenotype switching, and review molecular mechanisms that play crucial roles in the regulation of VSMC phenotypic plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
Song, Z., & Li, G. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9163-0 · Cited by 68
Smooth Muscle-Specific Genes Are Differentially Sensitive to Inhibition by Elk-1
Zhou, J., Hu, G., & Herring, B. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.9874-9885.2005 · Cited by 67
N-Cadherin Upregulation and Function in Response of Smooth Muscle Cells to Arterial Injury
Jones, M., Sabatini, P. J. B., Lee, F. S. H., Bendeck, M. P., & Langille, B. L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000036416.14084.5a · Cited by 64
N-Cadherin–Dependent Cell–Cell Contacts Promote Human Saphenous Vein Smooth Muscle Cell Survival
Koutsouki, E., Beeching, C. A., Slater, S. C., Blaschuk, O. W., Sala‐Newby, G. B., & George, S. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163183.27658.4b · Cited by 62
MicroRNA Regulation of Vascular Smooth Muscle Function and Phenotype
Mäegdefessel, L., Rayner, K. J., & Leeper, N. J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304877 · Cited by 57
Franco, C. A., & Gerhardt, H. (2012) · Nature · doi:10.1038/488465a · Cited by 56
Cadherin:catenin complex: A novel regulator of vascular smooth muscle cell behaviour
George, S. J., & Beeching, C. A. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.017 · Cited by 55
Pickering, J. G., Ford, C. M., & Chow, L. H. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00384-0 · Cited by 55
Xie, Y., Yu, J. H., Merenick, B. L., Ding, M., Fetalvero, K. M., Wagner, R. J., Mai, A., Gleim, S., Tucker, D. F., Birnbaum, M. J., et al. (2015) · Science Signaling · doi:10.1126/scisignal.2005482 · Cited by 54
McMurray, H. F., Parrott, D. P., & Bowyer, D. E. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90219-s · Cited by 53
Park, K. W., Yang, H., Youn, S., Yang, H.-J., Chae, I., Oh, B., Lee, M. M., Park, Y.-B., Choi, Y. S., Kim, H.-S., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081633.53390.b4 · Cited by 53
Vasudevan, H. N., & Soriano, P. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.10.005 · Cited by 52
Talasila, A., Yu, H., Ackers-Johnson, M. A., Bot, M., van Berkel, T. J. C., Bennett, M. R., Bot, I., & Sinha, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301000 · Cited by 51
Soluble N-Cadherin Overexpression Reduces Features of Atherosclerotic Plaque Instability
Lyon, C. A., Johnson, J. L., Williams, H., Sala-Newby, G. B., & George, S. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178087 · Cited by 51
Blindt, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.004 · Cited by 49
Soluble Jagged-1 Inhibits Neointima Formation by Attenuating Notch-Herp2 Signaling
Caolo, V., Schulten, H., Zhuang, Z. W., Murakami, M., Wagenaar, A., Verbruggen, S. E. L., Molin, D. G. M., & Post, M. J. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.217935 · Cited by 46
Murphy, J. G., Herrington, J. N., Granger, J. P., & Khalil, R. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00247.2002 · Cited by 44
Martín-Garrido, A., Williams, H. C., Lee, M. Y., Seidel-Rogol, B. L., Ci, X., Dong, J., Lassegue, B. P., Martín, A. S., & Griendling, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079657 · Cited by 42
Mao, C. D., Tahlil, O., Pueyo, M. E., Steg, P. G., & Soubrier, F. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.43 · Cited by 42
Eto, M., & Kitazawa, T. (2017) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.53.1 · Cited by 42
The GSK-3/β-catenin-signalling axis in smooth muscle and its relationship with remodelling
Gosens, R., Meurs, H., & Schmidt, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0269-8 · Cited by 35
Guo, X., Stice, S. L., Boyd, N. L., & Chen, S. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00298.2012 · Cited by 35
MicroRNA and vascular smooth muscle cell phenotype: new therapy for atherosclerosis?
Zhang, C. (2009) · Genome Medicine · doi:10.1186/gm85 · Cited by 32
Role of Jagged1 in Arterial Lesions After Vascular Injury
Wu, X., Zou, Y., Zhou, Q. G., Huang, L., Gong, H., Sun, A., Tateno, K., Katsube, K., Radtke, F., Ge, J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225144 · Cited by 31
Chow, W., Hou, G., & Bendeck, M. P. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.010 · Cited by 30
Cadherins in vascular smooth muscle cell (patho)biology: Quid nos scimus?
Frismantiene, A., Philippova, M., Erné, P., & Resink, T. J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.01.023 · Cited by 30
Self-citationEpigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function
Clifford, R. L., Singer, C. A., & John, A. E. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.07.002 · Cited by 27
MRTF-SRF signaling is required for seeding of HSC/Ps in bone marrow during development
Costello, P. S., Sargent, M., Maurice, D., Esnault, C., Foster, K., Anjos‐Afonso, F., & Treisman, R. (2015) · Blood · doi:10.1182/blood-2014-08-595603 · Cited by 27
Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury
Riascos‐Bernal, D. F., Chinnasamy, P., Gross, J. N., Almonte, V. M., Egaña-Gorroño, L., Parikh, D., Jayakumar, S., Guo, L., & Sibinga, N. E. S. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308643 · Cited by 23
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis
de Oliveira, C., Nguyen, H. V., Wijeysundera, H. C., Wong, W. W. L., Woo, G. W., Grootendorst, P. V., Liu, P. P., & Krahn, M. D. (2013) · CMAJ Open · doi:10.9778/cmajo.20130003 · Cited by 19
Frismantiene, A., Pfaff, D., Frachet, A., Coen, M., Joshi, M. B., Maslova, K., Bochaton‐Piallat, M., Erné, P., Resink, T. J., & Philippova, M. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.05.001 · Cited by 18
Self-citationTGFβ1 suppresses vascular smooth muscle cell motility by expression of N-cadherin
Nüßle, J. M., Giehl, K., Herzog, R., Stracke, S., & Menke, A. (2011) · Biological Chemistry · doi:10.1515/bc.2011.053 · Cited by 16
Christensen, A. (2001) · Cited by 12
Zhou, Y., Shi, Z., Singh, P., Yin, H. R., Yu, Y., Li, L., Walsh, M. P., Gui, Y., & Zheng, X. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25084 · Cited by 10
Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369441-6.00022-2 · Cited by 2
Phosphoinositide 3-Kinases, Protein Kinase B, and Signalling through the Insulin Receptor
Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369441-6.00018-0 · Cited by 1
Cited by
Jaminon, A., Reesink, K., Kroon, A., & Schurgers, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225694 · Cited by 305
Ning, R., Li, Y., Du, Z., Li, T., Sun, Q., Lin, L., Xu, Q., Duan, J., & Sun, Z. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102113 · Cited by 96
“Besides, vascular fibrosis is largely due to increased deposition of collagen I and collagen III in the vessel wall and perivascular areas, which can alter the passive pressure/diameter relationship of artery under higher pressure and induce a gradual hardening of vessel wall [11, 45].”
Cathelicidin Modulates Vascular Smooth Muscle Cell Phenotypic Switching through ROS/IL-6 Pathway
Dong, X., Wu, D., Zhang, Y., Jia, L., Pan, X., Sun, J., & Pan, L.-L. (2020) · Antioxidants · doi:10.3390/antiox9060491 · Cited by 25
Wu, J., Jin, L., Tan, J.-Y., Chen, X.-F., Wang, Q.-Q., Yuan, G.-Y., & Chen, T.-X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1375 · Cited by 17
Metadata
- Authors
- Frismantiene, A., Philippova, M., Erne, P., & Resink, T. J.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 52
- Pages
- 48-64
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2889322279
- Cited by
- 406
- References
- 236
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.